Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 5, 2007, Pages 447-456

  Mukhopadhyay, Asima ^a   Farrell, Tom ^a   Fraser, Robert B ^b   Ola, Bolarinde ^a  

^a JESSOP HOSPITAL FOR WOMEN   (United Kingdom)

^b Reader   (United Kingdom)

Author keywords

diabetes mellitus; insulin pump; metaanalysis; pregnancy; randomized controlled trials

Indexed keywords

INSULIN; ISOPHANE INSULIN; NEUTRAL INSULIN; PIG INSULIN;

BIRTH WEIGHT; CLINICAL TRIAL; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DATA BASE; DATA EXTRACTION; DELIVERY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE EXACERBATION; ELECTRONIC DATA INTERCHANGE; FETUS DEATH; GESTATIONAL AGE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INFORMATION PROCESSING; INSULIN PUMP; INTERMETHOD COMPARISON; KETOACIDOSIS; META ANALYSIS; METHODOLOGY; PERINATAL PERIOD; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RETINOPATHY; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

ADMINISTRATION, CUTANEOUS; ADULT; DIABETIC KETOACIDOSIS; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; ODDS RATIO; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 35548976210     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.03.062     Document Type: Review

References (40)

1. Dicker D., Feldberg D., Karp M., Yeshaya A., Samuel N., and Goldman J.A. Pre-conceptional diabetes control in Insulin dependent diabetes mellitus patients with continuous subcutaneous insulin infusion therapy. J Perinat Med 15 (1987) 161-167
2. Lucas M.J., Leveno K.J., Williams M.L., Raskin P., and Whalley P.J. Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol 161 (1989) 426-431
3. Gabbe S. New concepts and applications in the use of insulin pump during pregnancy. J Matern Fetal Med 9 (2000) 42-45
4. El- Sayed Y.Y., and Lyell D.J. New therapies for the pregnant patients with diabetes. Diabetes Technol Ther 3 (2001) 635-640
5. Lenhard M.J., and Reeves G.D. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 161 (2001) 2293-2300
6. Marcus A.O., and Fernandez M.P. Insulin pump therapy: acceptable alternative to injection therapy. Postgrad Med 99 (1996) 125-132
7. Colquitt J.L., Green G., Sidhu M.K., Hartwell D., and Waugh N. Clinical and cost effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 8 (2004) iii-95
8. Lepercq J. Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 33 (2005) 955-956
9. Hieronimus S., Cupelli C., Bongain A., Durand-Reville M., Berthier F., and Fenichel P. Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 33 (2005) 389-394
10. Caruso A., Lanzone A., Bianchi V., et al. Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic patients. Prenat Diagn 7 (1987) 41-50
11. Leveno K.J., Fortunato S.J., Raskin P., Williams M.L., and Whalley P.J. Continuous subcutaneous insulin infusion during pregnancy. Diabetes Res Clin Pract 4 (1988) 257-268
12. Kitzmiller J.L., Younger M.D., Hare J.W., et al. Continuous subcutaneous insulin therapy during early pregnancy. Obstet Gynecol 66 (1985) 606-611
13. Gonen R., Gonen Y., Ravina A., Abramovici H., Samberg Y., and Sharf M. Continuous subcutaneous insulin infusion. Improved blood glucose in pregnant diabetes. Clin Exp Obstet Gynecol 10 (1983) 87-90
14. Aucott S.W., Williams T.G., Hertz R.H., and Kalhan S.C. Rigorous management of insulin-dependent diabetes mellitus during pregnancy. Acta Diabetol 31 (1994) 126-129
15. Lapolla A., Dalfra M.G., Masin M., et al. Analysis of outcome of pregnancy in type 1 diabetes treated with insulin pump or conventional insulin therapy. Acta Diabetol 40 (2003) 143-149
16. Moore T.R., Hollingsworth D.R., Kolterman O., and Nager C. Continuous subcutaneous insulin infusion in an obese insulin-resistant pregnant woman with type 1I diabetes: accelerated fetal growth and neonatal complications. Obstet Gynecol 70 (1987) 480-485
17. Simmons D., Conroy C., Thompson C.F., and Scott D.J. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 24 (2001) 2078-2082
18. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 (1999) 1896-1900
19. Coustan D.R., Reece E.A., Sherwin R.S., et al. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 255 (1986) 631-636
20. Laatikainen L., Teramo K., Hieta-Heikurainen H., Koivisto V., and Pelkonen R. A controlled study of the influence of continuous subcutaneous insulin infusion treatment on diabetic retinopathy during pregnancy. Acta Med Scand 221 (1987) 367-376
21. Botta R.M., Sinagra D., Angelico M.-C., and Bompiani G.D. Comparison of intensified traditional insulin therapy and micropump therapy in pregnant women with type 1 diabetes mellitus. Minerva Med 77 (1986) 657-661
22. Burkart W., Hanker J.P., and Schneider H.P.G. Complications and fetal outcome in diabetic pregnancy: Intensified conventional versus insulin pump therapy. Gynecol Obstet Invest 26 (1988) 104-112
23. Nosari I., Maglio M.L., Lepore G., Cortinovis F., and Pagani G. Is continuous subcutaneous insulin infusion more effective than conventional insulin therapy in the treatment of pregnant diabetic women?. Diabetes Nutr Metab 6 (1993) 33-37
24. Carta Q., Meriggi E., Trossarelli G.F., et al. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy. Diabetes Metab 12 (1986) 121-129
25. Wender-Ozegowska E., Nikisch E., Pietryga M., Meissner W., and Hansz K. Glycemia control in diabetic pregnancies under intensive Insulin treatment with and without the aid of the Camit-Diacomp system. Ginekol Pol 68 (1997) 127-136
26. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 174 (1996) 1343-1353
27. Fenichel P., Verdino P., Melandri E., Boutte P., Harter M., and Gillet J.Y. Pregnancy, diabetes and the insulin pump. A better prognosis?. J Gynecol Obstet Biol Reprod Paris 12 (1983) 883-889
28. Gottlieb P.A., Frias J.P., Peters K.A., Chillara B., and Garg S.K. Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus. Treat Endocrinol 1 (2002) 235-240
29. Dandona P., Bolger J.P., Boag F., Fonesca V., and Abrams J.D. Rapid development and progression of proliferative retinopathy after strict diabetic control. Br Med J 290 (1985) 895-896
30. Lauritzen T., Frost-Larsen K., Larsen H.W., and Deckert T. The Steno Study Group. Two year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 Suppl 3 (1985) 74-79
31. Peden N.R., Braaten J.T., and McKendry J.B.R. Diabetic ketoacidosis during long term treatment with continuous subcutaneous insulin infusion. Diabetes Care 7 (1984) 1-5
32. Lindenbaum C., Menzin A., and Ludmir J. Diabetic ketoacidosis in pregnancy resulting from insulin pump failure. A case report. J Reprod Med 38 (1993) 306-308
33. Radermecker R.P., and Scheen A.J. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab Res Rev 20 (2004) 178-188
34. Attia N., Jones T.W., Holcombe J., and Tamborlane W.V. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 21 (1998) 817-821
35. Altman D.G. Better reporting of randomized controlled trials: the CONSORT statement. BMJ 313 (1996) 570-571
36. Gabbe S.G., Holing E., Temple P., and Brown Z.A. Benefits, risks, costs and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 182 (2000) 1283-1291
37. Guinn T.S., Bailey G.J., and Mecklenburg R.S. Factors relating to discontinuation of continuous subcutaneous infusion therapy. Diabetes Care 2 (1988) 46-51
38. Knee T.S., Seidensticker D.F., Walton J.L., Solberg L.M., and Lasseter D.H. A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series. Endocr Pract 9 (2003) 181-186
39. Pickup J.C., Kidd J., Burmiston S., and Yemane N. Determinants of glycemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 22 (2006) 232-237
40. Sacks D.A., Feig D.S., Liu I.L., and Wolde-Tsadik G. Managing type 1 diabetes in pregnancy: how near normal is necessary?. J Perinatol 26 (2006) 458-462